Intellectual Property

  • January 22, 2026

    Merck Can't Get Fed. Circ. To Reconsider Axing MS Drug Patents

    The Federal Circuit on Thursday refused to reconsider decisions invalidating Merck KGaA patents on the blockbuster multiple sclerosis drug Mavenclad, turning aside the German drugmaker's claim that the court set an unjust new rule that means inventors' work can later be used against them.

  • January 22, 2026

    Colo. Co. Can't Sue Target Again For Infringement, Court Told

    A Colorado-based clothing company cannot bring claims that Target infringed the company's registered copyright on several infant sleepwear products, the retail giant told a federal judge, arguing that a prior lawsuit against Target prevents the clothing company from suing it again.

  • January 22, 2026

    10th Circ. Partly Revives Pest Control Co.'s Fraud Claims

    The Tenth Circuit has partially revived a case brought by one pest control company against a competitor alleging the business rival bribed employees to turn over sales data, disagreeing with a lower court that the company had not shown financial losses.

  • January 22, 2026

    Patagonia Claims Activist 'Pattie Gonia' Rips Off TM In $1 Suit

    Patagonia Inc. has sued an activist who goes by the "Pattie Gonia" persona in California federal court, asking the court to block the drag queen from selling T-shirts and other merchandise and services that allegedly rip off its popular trademarks, while only seeking $1 in nominal damages.

  • January 22, 2026

    3rd Circ. Says Medical Pot Contract May Violate Federal Law

    The Third Circuit on Thursday vacated a medical cannabis company's win in a lawsuit filed by a consultant claiming that it had stolen his trade secrets for growing marijuana samples, finding it couldn't decide the appeal because the parties' contract might have violated federal drug law.

  • January 22, 2026

    AI Diagnostics Co.'s Patent Claims Don't Pass Alice Test

    A California federal judge has thrown out artificial intelligence diagnostics company Tempus AI's patent infringement suit against medical test-maker Guardant Health, finding claims in the patents weren't patent-eligible to begin with.

  • January 22, 2026

    USPTO Re-Ups Agreement With Major IP Offices Through 2029

    The U.S. Patent and Trademark Office has extended the Patent Prosecution Highway pilot program with four other intellectual property offices, which expedites review of patent applications that have been allowed in another country, for another three years.

  • January 22, 2026

    Simpson Thacher Adds Quinn Emanuel Atty To New SF Office

    A Quinn Emanuel Urquhart & Sullivan LLP attorney who worked on high-profile intellectual property matters representing Google and Jane Street Group has joined Simpson Thacher & Bartlett LLP as partner in its newly opened San Francisco office, the firm announced Thursday.

  • January 22, 2026

    Amazon Says IP Lawyer Can't Dodge Trademark Suit

    Amazon is pushing back against an intellectual property lawyer's effort to escape a lawsuit accusing him of conspiring with a Chinese company to sidestep a U.S. Patent and Trademark Office rule, arguing the claims were properly pled and that the Seattle federal court is the proper venue.

  • January 21, 2026

    NYC Sues Dr. Phil's Son To Stop NYPD Reality Show

    The city of New York on Wednesday sued the son of celebrity psychologist Dr. Phil in state court, claiming that he and his production company plan to air a reality television show about the New York Police Department that contains footage that would threaten the lives and safety of active police officers, witnesses and victims.

  • January 21, 2026

    PE Firm Used Jail Threats To Steer Cannabis Deal, Court Told

    A private equity firm can't free itself from a contract breach spat between a CBD and hemp product manufacturer and its business partner, as the firm not only interfered with the contract but also threatened to have people thrown in jail if they refused to capitulate, a North Carolina federal court heard Wednesday.

  • January 21, 2026

    Novartis Gets Win On Entresto Patent Tied To Earlier Ruling

    A Delaware federal judge found Wednesday that MSN Pharmaceuticals Inc. infringed a patent covering Novartis Pharmaceuticals Corp.'s blockbuster cardiovascular drug Entresto, saying the issue has already been litigated before.

  • January 21, 2026

    Licensing Deal Saves Cisco From Lionra Suit, Fed. Circ. Says

    The Federal Circuit rebuffed Lionra Technologies Ltd.'s efforts to save its patent infringement case against Cisco Systems Inc., with a panel finding Wednesday that a licensing agreement foreclosed the lawsuit and calling Lionra's characterization of the agreement "skewed."

  • January 21, 2026

    Allergan Says Fed. Circ.'s Ax Of $39M Win Misread Record

    A Federal Circuit decision reversing a $39 million verdict against Sandoz in Allergan's suit accusing it of infringing an eyelash growth drug patent misunderstood the evidence and was based on an "indisputably false" premise, Allergan said in a petition for rehearing Tuesday.

  • January 21, 2026

    NC Court Throws Duke A Lifeline In Transfer Battle With QB

    A North Carolina state judge allowed Duke University quarterback Darian Mensah to enter the NCAA transfer portal Wednesday, but prohibited him from signing with another school until ruling on Duke's request for an injunction that would keep him at the university.

  • January 21, 2026

    Disney Can't Dodge 'Toy Story 3' TM Claim On Remand

    A California federal judge has refused to grant Disney a partial win in a trademark infringement case brought by a stuffed animal manufacturer over the "Toy Story 3" character Lotso, ruling that the manufacturer had established a Lanham Act case against Disney before the U.S. Supreme Court considered the case.

  • January 21, 2026

    Pot Co., Rolling Paper Maker Settle 'Juicy' Trademark Suit

    A tobacco company and Colorado cannabis company told a federal judge that they have settled a trademark lawsuit in which the maker of Raw rolling papers had asked the court to permanently bar the cannabis company from using its product names.

  • January 21, 2026

    Tex-Mex Chain's 'Feeling' Isn't Trade Secret, NC Biz Court Told

    A chain of upscale Tex-Mex restaurants in North Carolina failed to specify the trade secrets a former manager is accused of stealing to replicate its dining concept at another restaurant in Missouri, defense counsel told a North Carolina Business Court judge on Wednesday.

  • January 21, 2026

    Fed. Circ. Won't Reinstate Text-Tracking Patent Case

    The Federal Circuit on Wednesday affirmed a lower court's decision declining a cellular data-tracking company's request for a new trial, rejecting the company's arguments that the district judge's claim construction had been erroneous.

  • January 21, 2026

    EcoFactor Can't Restore Thermostat IP Claims At Fed. Circ.

    Smart home energy company EcoFactor on Wednesday failed to persuade the Federal Circuit to revive claims in one of its smart thermostat patents following a Patent Trial and Appeal Board decision that invalidated the claims.

  • January 21, 2026

    Litigation Funder, Former GC Reach Deal In Trade Secrets Suit

    Litigation funder Siltstone Capital LLC and its former general counsel have reached a settlement in the company's lawsuit, alleging the GC used trade secrets to form a rival litigation funder.

  • January 21, 2026

    Widow Of 'Sophie's Choice' Author Settles Stage Rights Spat

    The 97-year-old widow of author William Styron has settled a suit by a playwright who claimed he held exclusive rights to the stage version of Styron's novel "Sophie's Choice," according to a filing in Massachusetts state court.

  • January 21, 2026

    Burford Capital Hires New Korea Exec Amid Growth Push

    Burford Capital LLC has hired a new executive to oversee its operations in South Korea as the litigation funder aims to double its portfolio to roughly $15 billion by 2030, in part by expanding its geographic footprint.

  • January 21, 2026

    Maxim Says Playboy Ripped Off Its Modeling Contest

    Maxim has sued Playboy in Manhattan federal court for trade secret misappropriation and copyright infringement, accusing Playboy of copying Maxim's online modeling competition by using the same mechanics and architecture when launching a contest of its own.

  • January 21, 2026

    Fed. Circ. Gives Apple New Shot At Axing Smart Mobile Patent

    The Federal Circuit on Wednesday undid the Patent Trial and Appeal Board's finding that Apple failed to show a Smart Mobile wireless patent was invalid, saying the first claim was unpatentable and that the board needs to rethink the other challenged portions.

Expert Analysis

  • How Chinese Utility Models Fit Into Global IP Strategies

    Author Photo

    Recent guidelines from the China National Intellectual Property Administration put the spotlight on the value of Chinese utility models — especially for device-focused innovations — and the interplay between utility models and conventional Chinese patents, say attorneys at Foley & Lardner.

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • Higher Expectations For 'Schedule A' IP Suits On The Horizon

    Author Photo

    Two 2025 rulings may reflect a growing judicial discomfort with the current state of Schedule A litigation — intellectual property lawsuits that typically involve brand owners suing multiple defendants doing business on e-commerce platforms — and that evidentiary submissions and temporary restraining order requests may face more rigorous review, says Dylan Scher at Quinn Emanuel.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • Trending At The PTAB: The Policies That Are Redefining IPR

    Author Photo

    The evolution of the Patent Trial and Appeal Board's inter partes review institution regime last year, coupled with the policy considerations behind that evolution, marks a shift toward greater gatekeeping of the U.S. Patent and Trademark Office's resources and patent enforcement rights, say attorneys at Finnegan.

  • Reviewing 2025's Artificial Intelligence Disputes Over IP

    Author Photo

    2025 brought the first major fair use rulings involving generative artificial intelligence, and in 2026 courts will weigh in on more discovery disputes, renewed motions to dismiss, class certification challenges and fair use defenses that could shape the course of future AI litigation, say attorneys at Debevoise.

  • Trending At The PTAB: The Journey Of IPR Institution In 2025

    Author Photo

    Over the course of 2025, inter partes review institution at the Patent Trial and Appeal Board evolved into a more restrictive, policy-driven regime with reshaped discretionary briefing and assessment, and increasing procedural requirements, say attorneys at Finnegan.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • 5 Trade Secret Developments To Follow In 2026

    Author Photo

    Watch for major developments in trade secret law this year, especially as courts clarify the reach of U.S. law internationally, the availability of trade secret damages and more, say attorneys at Faegre Drinker.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • Opinion

    Judges Carry Onus To Screen Expert Opinions Before Juries

    Author Photo

    Recent Second Circuit arguments in Acetaminophen Products Liability Litigation implied a low bar for judicial gatekeeping of expert testimony, but under amended Rule 702 of the Federal Rules of Evidence, judges must rigorously scrutinize expert opinions before allowing them to reach juries, says Lee Mickus at Evans Fears.

  • Labubu Highlights Evolving IP Strategies In Modern Markets

    Author Photo

    Pop Mart's decision not to pursue U.S. patents for its Labubu plush dolls — relying instead on expressive rights — is rational given the nature of the product and the velocity of the market, and also underscores broader structural issues that may hold the U.S. patent system from keeping pace with modern markets, says Tina Dorr at Barnes & Thornburg.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • Opinion

    Justices Should Clarify Loper Bright Doctrine Via Patent Case

    Author Photo

    The U.S. Supreme Court should use the Lynk Labs v. Samsung patent case to provide urgently needed guidance on how last year’s Loper Bright decision should be applied to real-world questions of agency authority in the post-Chevron world, says Timothy Hsieh at Oklahoma City University School of Law.

  • 7 Strategies To Optimize Impact Of Direct Examination

    Author Photo

    Direct examination is a make-or-break opportunity to build a witness’s credibility, so attorneys should adopt a few tactics — from asking so-called trust-fall questions to preemptively addressing weaknesses — to drive impact and retention with the fact-finder, says Allison Rocker at Baker McKenzie.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.